Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ORCHID PHARMA vs DISHMAN PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ORCHID PHARMA DISHMAN PHARMA ORCHID PHARMA/
DISHMAN PHARMA
 
P/E (TTM) x 42.1 30.0 140.3% View Chart
P/BV x 7.8 3.3 231.6% View Chart
Dividend Yield % 0.0 0.7 -  

Financials

 ORCHID PHARMA   DISHMAN PHARMA
EQUITY SHARE DATA
    ORCHID PHARMA
Mar-23
DISHMAN PHARMA
Mar-16
ORCHID PHARMA/
DISHMAN PHARMA
5-Yr Chart
Click to enlarge
High Rs439374 117.1%   
Low Rs273129 211.9%   
Sales per share (Unadj.) Rs163.1197.0 82.8%  
Earnings per share (Unadj.) Rs13.521.2 63.9%  
Cash flow per share (Unadj.) Rs27.034.7 77.7%  
Dividends per share (Unadj.) Rs02.00 0.0%  
Avg Dividend yield %00.8 0.0%  
Book value per share (Unadj.) Rs168.7179.9 93.8%  
Shares outstanding (eoy) m40.8280.70 50.6%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x2.21.3 170.7%   
Avg P/E ratio x26.311.9 221.3%  
P/CF ratio (eoy) x13.27.3 182.0%  
Price / Book Value ratio x2.11.4 150.7%  
Dividend payout %09.4 0.0%   
Avg Mkt Cap Rs m14,52220,307 71.5%   
No. of employees `000NANA-   
Total wages/salary Rs m6545,355 12.2%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m6,65915,898 41.9%  
Other income Rs m194265 73.2%   
Total revenues Rs m6,85316,163 42.4%   
Gross profit Rs m1,2354,103 30.1%  
Depreciation Rs m5481,091 50.2%   
Interest Rs m329944 34.8%   
Profit before tax Rs m5522,334 23.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m0624 0.0%   
Profit after tax Rs m5521,710 32.3%  
Gross profit margin %18.525.8 71.9%  
Effective tax rate %026.7 0.0%   
Net profit margin %8.310.8 77.1%  
BALANCE SHEET DATA
Current assets Rs m5,01011,018 45.5%   
Current liabilities Rs m3,7199,517 39.1%   
Net working cap to sales %19.49.4 205.4%  
Current ratio x1.31.2 116.4%  
Inventory Days Days5757 100.6%  
Debtors Days Days1,1803 33,726.5%  
Net fixed assets Rs m7,24218,787 38.5%   
Share capital Rs m408161 252.9%   
"Free" reserves Rs m6,47814,354 45.1%   
Net worth Rs m6,88614,516 47.4%   
Long term debt Rs m1,4884,189 35.5%   
Total assets Rs m12,25229,805 41.1%  
Interest coverage x2.73.5 77.2%   
Debt to equity ratio x0.20.3 74.9%  
Sales to assets ratio x0.50.5 101.9%   
Return on assets %7.28.9 80.8%  
Return on equity %8.011.8 68.1%  
Return on capital %10.517.5 60.1%  
Exports to sales %81.924.9 329.0%   
Imports to sales %37.63.7 1,004.8%   
Exports (fob) Rs m5,4523,956 137.8%   
Imports (cif) Rs m2,501594 420.9%   
Fx inflow Rs m5,4524,952 110.1%   
Fx outflow Rs m2,726697 391.3%   
Net fx Rs m2,7264,255 64.1%   
CASH FLOW
From Operations Rs m1832,786 6.6%  
From Investments Rs m-312-1,529 20.4%  
From Financial Activity Rs m312-941 -33.1%  
Net Cashflow Rs m183317 57.8%  

Share Holding

Indian Promoters % 69.8 61.4 113.7%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 18.6 23.0 81.2%  
FIIs % 4.1 12.0 34.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 30.2 38.6 78.1%  
Shareholders   36,931 52,291 70.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ORCHID PHARMA With:   SUN PHARMA    DIVIS LABORATORIES    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on Orchid Pharma vs Dishman Pharma

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Orchid Pharma vs Dishman Pharma Share Price Performance

Period Orchid Pharma Dishman Pharma S&P BSE HEALTHCARE
1-Day 0.29% 2.87% 1.18%
1-Month -13.47% -2.45% -0.75%
1-Year 175.44% 96.38% 61.82%
3-Year CAGR -23.47% 89.34% 18.16%
5-Year CAGR 184.97% 38.20% 19.79%

* Compound Annual Growth Rate

Here are more details on the Orchid Pharma share price and the Dishman Pharma share price.

Moving on to shareholding structures...

The promoters of Orchid Pharma hold a 69.8% stake in the company. In case of Dishman Pharma the stake stands at 61.4%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Orchid Pharma and the shareholding pattern of Dishman Pharma.

Finally, a word on dividends...

In the most recent financial year, Orchid Pharma paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of 0.0%.

Dishman Pharma paid Rs 2.0, and its dividend payout ratio stood at 9.4%.

You may visit here to review the dividend history of Orchid Pharma, and the dividend history of Dishman Pharma.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.